Irbesartan and Hydrochlorothiazide Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20213255
Indications:
It is used for the treatment of essential hypertension.
This fixed - dose combination is used for the treatment of patients whose blood pressure cannot be effectively controlled by using irbesartan or hydrochlorothiazide alone.
Administration:
Take orally, either on an empty stomach or during meals. The commonly used starting and maintenance dose is 1 tablet once a day, and it can be increased to 2 tablets once a day according to the condition.
This product is used for the treatment of patients whose blood pressure cannot be effectively controlled by using irbesartan or hydrochlorothiazide alone.
It is recommended that patients adjust the dosage of single components (i.e., irbesartan or hydrochlorothiazide) in combination therapy before using the fixed - dose combination. When the dosage of each single drug in the combination therapy is fixed, this compound can be used as a substitute.
The following situations can be directly converted from single - component to combination therapy: The 150 mg/12.5 mg combination of this product can be used for patients whose blood pressure cannot be effectively controlled by using 150 mg of irbesartan alone or hydrochlorothiazide alone.
A daily dose greater than 300 mg of irbesartan/25 mg of hydrochlorothiazide is not recommended. If necessary, this product can be used in combination with other antihypertensive drugs.
Specifications:
150mg/12.5mg × 14 tablets
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.